Pregnancy decision-making in women with multiple sclerosis treated with natalizumab
Emilio Portaccio(University of Florence), Mauro Zaffaroni(Associazione Italiana Sclerosi Multipla), Angelo Ghezzi, Lucia Moiola(Vita-Salute San Raffaele University), Alessandra Protti(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Marta Radaelli(Humboldt-Universität zu Berlin), Paolo Confalonieri(Fondazione IRCCS Istituto Neurologico Carlo Besta), Carla Tortorella(Carlo Forlanini Hospital), Maria Giovanna Marrosu(University of Cagliari), María Trojano(University of Bari Aldo Moro), Lorenzo Razzolini(University of Florence), Alice Laroni(Azienda Ospedaliera di Padova), Bahia Hakiki, Valentina Torri Clerici, Isabella Righini, Gıancarlo Comı(Casa di Cura Columbus), Antonio Uccelli(Istituti di Ricovero e Cura a Carattere Scientifico), Maria Pia Amato(University of Florence), Roberta Lanzillo(University of Naples Federico II), R. Marazzi, Damiano Paolicelli(University of Bari Aldo Moro), Luisa Pastò(University of Florence), Laura De Giglio(Vita-Salute San Raffaele University), Paola Cavalla, Paolo Gallo(University of Padua), Marta Giannini(Vita-Salute San Raffaele University), Francesco Patti(University of Catania), Emanuela Susani, Carlo Pozzilli(Sapienza University of Rome), Eleonora Cocco(University of Cagliari), Claudio Solaro(Rina Services (Italy)), G. Siracusa, Vincenzo Brescia Morra(Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari), Vittorio Martinelli, Paolo Bellantonio(Vita-Salute San Raffaele University), V. Martinelli(Vita-Salute San Raffaele University), Pietro Annovazzi(Vita-Salute San Raffaele University), Francesca Rinaldi(Azienda Ospedale - Università Padova)
Cited by 123
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k
Multiple Sclerosis Severity Score
|Neurology|2005|959